You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: aspirin lowers the risk for MI but not for stroke in people who do not have established vascular disease

https://doi.org/10.1136/ebm.5.6.174

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) Arch Neurol 57, 326. Hart RG, Halperin JL, McBride R. , et al. . Aspirin for the primary prevention of stroke and other major vascular events. Meta-analysis and hypotheses. . . Mar;. :. –32..
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: For people who do not have clinically recognised vascular disease, is aspirin effective for reducing stroke and other vascular events?

    Data sources

    Studies were identified by searching for English language articles in {Medline}* (1980–98) with the terms clinical trial, aspirin, and stroke; the Cochrane Collaboration Trials Registry; the Antiplatelet Trialists' Collaboration lists of publications; and bibliographies of review articles.

    Study selection

    Studies were selected if they were randomised controlled trials or large observational studies of aspirin in any dose; trials compared aspirin with placebo for primary prevention of stroke; data were provided on people who did not have established vascular disease at baseline; and outcomes were stroke, myocardial infarction, or other major vascular …

    View Full Text

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Dr R G Hart, Department of Medicine (Neurology), University of Texas Health Science Center MSC7883, 7703 Floyd Curl Drive, San Antonio, TX 78229–3900, USA. Fax +1 210 567 4659.

    • ↵* Information provided by author.